The roughly 15 million customers of genetic data outfit 23andMe may be at greater risk than they realize, suggests a new New York Times story that argues the company’s near-term woes could become problematic for others for a very long time if it can’t continue as a going concern. Certainly, with each passing day, the […]
© 2024 TechCrunch. All rights reserved. For personal use only....